Subscribe free

Perspectives, Opinions and Curiosities ·

Ciprofloxacin Still Has a Place, But a Narrow One

Ciprofloxacin is now a targeted option in surgery, not a default, because its adverse effects can seriously disrupt surgical recovery. This narrative review found the best use is in stable patients with culture-confirmed, susceptible gram-negative infection after source control, especially urinary infection needing oral step-down.

  • Tendon rupture, neurotoxicity, dysglycemia, QT effects and hypersensitivity can all have outsized surgical consequences.
  • Older age, corticosteroid use, renal dysfunction and common comedications raise the risk further.

Where it fits: Use ciprofloxacin only after susceptibility is confirmed and no equally effective, safer oral option exists. Screen for interactions and risk factors before prescribing.

Review by Condorelli GA, Fuochi V, Berbece S and Drago F in BMC Surg

Copyright © 2026 Elsevier Inc. All rights reserved.

read the whole article in BMC Surg

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Perspectives, Opinions and Curiosities.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Perspectives, Opinions and Curiosities

The latest stitches

Ann Surg Oncol10 Nov 2026

Most CGSO fellowship graduates do not publish consistently after training

Only 43% of graduates published after at least two years in independent practice, and just 10% did basic or translational research. Among 232 graduates, 118 (51%) practiced at university-based flagship hospitals, where publication was strongly associated with output.

All papers in Perspectives, Opinions and Curiosities →